AVDL · Categories · Form 4

AVDL - SEC Form 4 insider transactions

Avadel Pharmaceuticals plc (AVDL) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AVDL

• 113d
  Former 10% Owner Weiss Asset Management Lp sold $233,353,092 worth of Ordinary Shares (11,112,052 units at $21.00) (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  SEC Form 4 filed by Chief Operating Officer Rodriguez Susan

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Director Thornton Peter J. returned $2,416,260 worth of Ordinary Shares to the company (115,060 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Gen. Counsel & Corp. Secretary Seurer Jerad G. returned $493,416 worth of Ordinary Shares to the company (23,496 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Director Palczuk Linda returned $1,657,005 worth of Ordinary Shares to the company (78,905 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Chief Financial Officer Mchugh Thomas S returned $2,108,400 worth of Ordinary Shares to the company (100,400 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Director Mccamish Mark Anthony returned $1,869,525 worth of Ordinary Shares to the company (89,025 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Director Glass Geoffrey Michael returned $3,506,664 worth of Ordinary Shares to the company (166,984 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Director Ende Eric J returned $4,618,005 worth of Ordinary Shares to the company (219,905 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Chief Executive Officer Divis Gregory J returned $4,643,205 worth of Ordinary Shares to the company (221,105 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 119d
  Director Amin Naseem returned $462,000 worth of Ordinary Shares to the company (22,000 units at $21.00), closing all direct ownership in the company (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 125d
  Director Mccamish Mark Anthony gifted 67,025 units of Ordinary Shares and received a gift of 67,025 units of Ordinary Shares (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 269d
  SEC Form 4 filed by Director Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 269d
  SEC Form 4 filed by Director Glass Geoffrey Michael

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 315d
  Director Mccamish Mark Anthony was granted 11,000 units of Ordinary Shares, increasing direct ownership by 100% to 22,000 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 315d
  Director Palczuk Linda was granted 11,000 units of Ordinary Shares, increasing direct ownership by 16% to 78,900 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 315d
  Director Thornton Peter J. was granted 11,000 units of Ordinary Shares, increasing direct ownership by 11% to 115,055 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 315d
  Director Glass Geoffrey Michael was granted 11,000 units of Ordinary Shares, increasing direct ownership by 100% to 22,000 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 315d
  Director Ende Eric J was granted 11,000 units of Ordinary Shares, increasing direct ownership by 5% to 219,900 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 315d
  Director Amin Naseem was granted 11,000 units of Ordinary Shares, increasing direct ownership by 100% to 22,000 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 394d
  SEC Form 4 filed by Chief Operating Officer Rodriguez Susan

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 461d
  Gen. Counsel & Corp. Secretary Seurer Jerad G. was granted 14,700 units of Ordinary Shares, increasing direct ownership by 167% to 23,495 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 461d
  Chief Financial Officer Mchugh Thomas S was granted 12,600 units of Ordinary Shares, increasing direct ownership by 14% to 100,400 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 461d
  Chief Executive Officer Divis Gregory J was granted 52,000 units of Ordinary Shares, increasing direct ownership by 33% to 211,100 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 499d
  SEC Form 4 filed by Director Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 531d
  Director Palczuk Linda gifted 3,500 units of Ordinary Shares, decreasing direct ownership by 5% to 62,900 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 539d
  SEC Form 4 filed by Director Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 633d
  SEC Form 4 filed by Director Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 636d
  SEC Form 4 filed by Director Glass Geoffrey Michael

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 679d
  Director Palczuk Linda was granted 11,000 units of Ordinary Shares, increasing direct ownership by 21% to 63,400 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 679d
  Director Thornton Peter J. was granted 11,000 units of Ordinary Shares, increasing direct ownership by 13% to 94,055 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 679d
  Director Ende Eric J was granted 11,000 units of Ordinary Shares, increasing direct ownership by 7% to 178,900 units (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 679d
  Director Amin Naseem was granted 11,000 units of Ordinary Shares (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 679d
  Director Mccamish Mark Anthony was granted 11,000 units of Ordinary Shares (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 679d
  Director Glass Geoffrey Michael was granted 11,000 units of Ordinary Shares (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 751d
  SEC Form 4 filed by Amin Naseem

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 829d
  SEC Form 4 filed by Kim Richard J

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 829d
  SEC Form 4 filed by Mchugh Thomas S

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 829d
  SEC Form 4 filed by Divis Gregory J

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 895d
  Mccamish Mark Anthony sold $1,089,750 worth of ADSs (75,000 units at $14.53) (SEC Form 4)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1014d
  SEC Form 4 filed by Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1014d
  SEC Form 4 filed by Glass Geoffrey Michael

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1031d
  SEC Form 4: Mccamish Mark Anthony sold $432,614 worth of ADSs (28,975 units at $14.93)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1032d
  SEC Form 4: Mchugh Thomas S bought $28,900 worth of ADSs (2,000 units at $14.45), increasing direct ownership by 3% to 78,500 units

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1035d
  SEC Form 4: Glass Geoffrey Michael bought $187,600 worth of ADSs (14,000 units at $13.40)

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1036d
  SEC Form 4: Divis Gregory J bought $131,997 worth of ADSs (10,000 units at $13.20), increasing direct ownership by 7% to 159,100 units

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1043d
  SEC Form 4 filed by Ende Eric J

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1043d
  SEC Form 4 filed by Glass Geoffrey Michael

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1043d
  SEC Form 4 filed by Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1043d
  SEC Form 4 filed by Mccamish Mark Anthony

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1043d
  SEC Form 4 filed by Thornton Peter J.

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1102d
  SEC Form 4 filed by Mchugh Thomas S

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1102d
  SEC Form 4 filed by Kim Richard J

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1102d
  SEC Form 4 filed by Divis Gregory J

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1119d
  SEC Form 4 filed by Ende Eric J

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1128d
  SEC Form 4 filed by Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1234d
  SEC Form 4 filed by Palczuk Linda

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1261d
  SEC Form 4: Palczuk Linda bought $14,405 worth of ADSs (2,000 units at $7.20), increasing direct ownership by 4% to 49,900 units

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1289d
  SEC Form 4: Mchugh Thomas S bought $39,000 worth of ADSs (5,000 units at $7.80), increasing direct ownership by 7% to 76,500 units

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)
• 1296d
  SEC Form 4: Ende Eric J bought $156,050 worth of ADSs (20,000 units at $7.80), increasing direct ownership by 15% to 154,900 units

  4 - AVADEL PHARMACEUTICALS PLC (0001012477) (Issuer)

Other AVDL categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends